HARBIN GLORIA PHARMACEUTICALS Co., LTD (SHE:002437)

China flag China · Delayed Price · Currency is CNY
3.380
+0.050 (1.50%)
Feb 24, 2026, 3:04 PM CST
Market Cap7.43B +27.4%
Revenue (ttm)2.25B -7.5%
Net Income293.04M +265.4%
EPS0.13 +249.0%
Shares Out2.23B
PE Ratio26.16
Forward PE30.27
Dividendn/a
Ex-Dividend Daten/a
Volume36,054,572
Average Volume90,429,773
Open3.370
Previous Close3.330
Day's Range3.330 - 3.390
52-Week Range2.120 - 4.080
Beta0.27
RSI50.37
Earnings DateApr 28, 2026

About SHE:002437

HARBIN GLORIA PHARMACEUTICALS Co., LTD engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China. Its products include cardiovascular and cerebrovascular, musculoskeletal, vitamins, electrolyte, diabetes-lowering, analgesics, digestive system and metabolism, anti-infective, and anti-tumor drugs. Harbin Gloria Pharmaceuticals Co., Ltd was founded in 2000 and is based in Harbin, the People’s Republic of China. [Read more]

Sector Healthcare
Founded 2000
Employees 2,703
Stock Exchange Shenzhen Stock Exchange
Ticker Symbol 002437
Full Company Profile

Financial Performance

In 2024, SHE:002437's revenue was 2.44 billion, a decrease of -7.06% compared to the previous year's 2.63 billion. Earnings were 232.76 million, an increase of 93.43%.

Financial Statements